Cohere Health Names Finance Industry Veteran Robert Shepardson as New Chief Financial Officer [Yahoo! Finance]
Certara, Inc. (CERT)
Company Research
Source: Yahoo! Finance
BOSTON, Mass. Oct. 18, 2024 /PRNewswire/ -- Cohere Health ®, a recognized leader in clinical intelligence and prior authorization automation, has appointed Robert (Bob) Shepardson as Chief Financial Officer. Shepardson will steer financial strategy and operational scaling amid a period of substantial revenue growth and strategic activity facilitated by Cohere's recent capital infusion. Shepardson brings over 35 years of expertise in high-growth healthcare and technology sectors, with a proven track record of leading businesses through both organic and inorganic growth strategies across private equity, venture capital, and publicly traded environments. His extensive industry knowledge, combined with a seasoned approach to financial leadership and a strong strategic vision, uniquely positions him to lead Cohere's finance, partnerships, and inorganic initiatives as the company scales its innovative solutions for health plan clients and beyond. "With his extensive background in healt
Show less
Read more
Impact Snapshot
Event Time:
CERT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERT alerts
High impacting Certara, Inc. news events
Weekly update
A roundup of the hottest topics
CERT
News
- Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions [Yahoo! Finance]Yahoo! Finance
- Certara Appoints Dr. Adrian McKemey as President of Drug Development SolutionsGlobeNewswire
- Certara, Inc. (NASDAQ: CERT) had its price target raised by analysts at Barclays PLC from $12.00 to $13.00. They now have an "equal weight" rating on the stock.MarketBeat
- Certara, Inc. (NASDAQ: CERT) had its "market perform" rating re-affirmed by analysts at William Blair.MarketBeat
- Certara, Inc. (NASDAQ: CERT) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $17.00 price target on the stock.MarketBeat
CERT
Earnings
- 2/26/25 - Beat
CERT
Sec Filings
- 3/10/25 - Form 3
- 3/5/25 - Form 8-K
- 2/26/25 - Form 10-K
- CERT's page on the SEC website